RYGB and the Gastric Adipose Axis

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Obesity
Interventions
DRUG

human ghrelin

0.5-1 pmol/kg.min of human ghrelin administered by IV two times

OTHER

very low calorie diet

standard very low calorie diet that is prescribed for all RYGB patients after their operation

PROCEDURE

Hyperinsulinemic/Euglycemic Clamp

Insulin and glucose infusions to measure glucose kinetics.

Trial Locations (1)

34232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Vanderbilt University

OTHER

NCT01474785 - RYGB and the Gastric Adipose Axis | Biotech Hunter | Biotech Hunter